首页> 外文期刊>World Journal of Gastroenterology >Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis
【24h】

Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis

机译:酒精性肝硬化患者的脂肪因子水平与肝脏疾病的严重程度有关

获取原文
           

摘要

AIM: To investigate the adipokine levels of leptin, adiponectin, resistin, visfatin, retinol-binding protein 4 (RBP4), apelin in alcoholic liver cirrhosis (ALC). METHODS: Forty non-diabetic ALC patients [median age: 59 years, males: 35 (87.5%), Child-Pugh (CP) score: median 7 (5-12), CP A/B/C: 18/10/12, Model for End-stage Liver Disease (MELD): median 10 (6-25), follow-up: median 32.5 mo (10-43)] were prospectively included. The serum adipokine levels were estimated in duplicate by ELISA. Somatometric characteristics were assessed with tetrapolar bioelectrical impedance analysis. Pearson’s rank correlation coefficient was used to assess possible associations with adipokine levels. Univariate and multivariate Cox regression analysis was used to determine independent predictors for overall survival. RESULTS: Body mass index: median 25.9 (range: 20.1-39.3), fat: 23.4% (7.6-42.1), fat mass: 17.8 (5.49-45.4), free fat mass: 56.1 (39.6-74.4), total body water (TBW): 40.6 (29.8-58.8). Leptin and visfatin levels were positively associated with fat mass (P P = 0.027, respectively) and RBP4 with TBW (P = 0.025). Median adiponectin levels were significantly higher in CPC compared to CPA (CPA: 7.99 ± 14.07, CPB: 7.66 ± 3.48, CPC: 25.73 ± 26.8, P = 0.04), whereas median RBP4 and apelin levels decreased across the spectrum of disease severity (P = 0.006/P = 0.034, respectively). Following adjustment for fat mass, visfatin and adiponectin levels were significantly increased from CPA to CPC (both P P P = 0.029). CONCLUSION: Adipokines are associated with deteriorating liver function in a complex manner in patients with alcoholic liver cirrhosis.
机译:目的:研究酒精性肝硬化(ALC)中瘦素,脂联素,抵抗素,维斯汀,视黄醇结合蛋白4(RBP4)和阿珀林的脂肪因子水平。方法:四十名非糖尿病ALC患者[中位年龄:59岁,男性:35(87.5%),Child-Pugh(CP)评分:中位数7(5-12),CP A / B / C:18/10 / 12,终末期肝病模型(MELD):中位10(6-25),随访:中位32.5 mo(10-43)]。通过ELISA一式两份估计血清脂肪因子水平。通过四极生物电阻抗分析评估体测特征。皮尔逊(Pearson)的等级相关系数用于评估与脂肪因子水平的可能关联。单因素和多因素Cox回归分析用于确定整体生存率的独立预测因子。结果:体重指数:中位数25.9(范围:20.1-39.3),脂肪:23.4%(7.6-42.1),脂肪质量:17.8(5.49-45.4),游离脂肪质量:56.1(39.6-74.4),全身水(TBW):40.6(29.8-58.8)。瘦素和visfatin水平与脂肪量(分别为P P = 0.027)和RBP4与TBW(P = 0.025)呈正相关。与CPA相比,CPC中的脂联素中位数水平明显更高(CPA:7.99±14.07,CPB:7.66±3.48,CPC:25.73±26.8,P = 0.04),而中位数RBP4和apelin水平在整个疾病严重度范围内均下降(P = 0.006 / P = 0.034)。调整脂肪量后,从CPA到CPC的visfatin和脂联素水平均显着增加(均为P P P = 0.029)。结论:酒精性肝硬化患者中,脂肪因子与肝功能恶化有复杂关系。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号